Cancer 14 Best Biotech Stocks for a Blockbuster 2021 | Kiplinger kiplinger.com - Dana Blankenhorn Whether you're conservative or aggressive, this list of 2021's best biotech and biopharmaceutical stocks has at least a few options to fit your …
Tesla A big Tesla stock bull says this is one of the most common misperceptions on Tesla yahoo.com - Brian Sozzi Wedbush managing director and Tesla (TSLA) bull Dan Ives contends it’s not just day-traders blinded by the magic of Elon Musk gobbling up shares of …
Business InsiderFinance JPMorgan rolls out a supercharged tech trade designed to amplify gains in stocks like Tesla, report says Business Insider - Ben WinckTech stocks have led the stock market to several record highs in 2020. JPMorgan thinks investors want to double down on the sector. The bank is letting investors in on a new trade that amplifies bets three...
ForbesStocks These Stocks Will Outperform The Market If A Coronavirus Vaccine Is Approved, According To Experts Forbes - Sergei KlebnikovAs optimism on Wall Street grows about potential FDA approval for a coronavirus vaccine, here are six stocks that could make outsized gains and rebound on the news, according to experts from Stifel. Key...
Business InsiderBiogen A $44 billion biotech just got some good news from the FDA about a key Alzheimer's drug, and the stock is soaring verified_publisherBusiness Insider - Barbara SmithThe biotech giant Biogen just said US regulators will give its potential Alzheimer's treatment a speedy review, sending the company's stock soaring. The US Food and Drug Administration will rule on the...
The Motley FoolInvesting Could This Obscure Biotech Stock Make You a Fortune? verified_publisherThe Motley Fool - Mark Prvulovic Two major catalysts on the horizon could send Omeros' stock soaring. What should investors think? Many investors have made tons of money by investing …
Business InsiderMorgan Stanley Morgan Stanley shares European stocks across 5 sectors that will soar in a post-COVID recovery verified_publisherBusiness Insider - Kari McMahonMorgan Stanley brought together five separate equity research teams to understand which European activity-based stocks damaged by the pandemic were still discounted for a post-COVID recovery, in a new...
